Daiwa Securities Group Inc. Reata Pharmaceuticals Inc Transaction History

Daiwa Securities Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$30.85 - $93.17 $555 - $1,677	18 Added 16.67%	126 $11,000
Q3 2021 Nov 05, 2021	BUY	$100.0 - $143.02 $4,600 - $6,578	46 Added 74.19%	108 $11,000
Q1 2021 May 03, 2021	BUY	$94.25 - $132.81 $754 - $1,062	8 Added 14.81%	62 $6,000
Q4 2020 Feb 04, 2021	SELL	$102.03 - $184.62 $10,815 - $19,569	-106 Reduced 66.25%	54 $7,000
Q3 2020 Nov 02, 2020	BUY	$93.53 - $163.34 $654 - $1,143	7 Added 4.58%	160 $16,000
Q1 2019 Apr 26, 2019	BUY	$51.9 - $101.79 $2,231 - $4,376	43 Added 39.09%	153 $13,000
Q1 2018 May 02, 2018	BUY	$20.0 - $30.19 $2,200 - $3,320	110 New	110 $2,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.